AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Hourly Market Review - Apr 30, 2025 15 PM
Generated by AI AgentAinvest Market Brief
Wednesday, Apr 30, 2025 3:00 pm ET1min read
Movers of the hour:
Regulus Therapeutics is up 134.05% at $7.89.
Regencell Bioscience is up 66.66% at $52.67.
Ruanyun Edai is up 60.75% at $8.15.
Rocky Brands is up 47.03% at $20.51.
Cantor Equity is up 41.14% at $46.21.
Here are the top stocks upgraded by Wall Street analyst:
Apple has received a rating of Buy from Morgan Stanley with target price increased to $235 from $220.
Apple has received a rating of Neutral from UBS with target price dropped to $210 from $236.
Apple has received a rating of Strong Buy from Goldman Sachs with target price dropped to $256 from $259.
Apple has received a rating of Strong Buy from Needham with target price increased to $225 from $225.
Apple has received a rating of Strong Buy from DA Davidson with target price dropped to $230 from $290.
Apple has received a rating of Buy from JP Morgan with target price dropped to $245 from $270.
Apple has received a rating of Strong Buy from Citigroup with target price dropped to $245 from $275.
Apple has received a rating of Neutral from Jefferies with target price dropped to $168 from $202.
Apple has received a rating of Sell from Keybanc with target price dropped to $170 from $200.
Ainvest Market Brief
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Morning Market Pulse: Trump’s Federal Pay Raise & Japan’s Policy Shift Drive Pre-Market Moves
Dec.19 2025
What to Trade Today: Volatility and Inflows Drive Pre-Market Moves
Dec.19 2025
U.S. Corporate Actions | Ticker Changes and Dividend Announcements Highlight Activity
Dec.19 2025
Morning Market Pulse: Trump’s Marijuana Rescheduling and AI Policy Shifts
Dec.18 2025
What to Trade Today: Mixed Macro Signals and Short-Term Glimmers in the Diagonal
Dec.18 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet